Search

Search Constraints

You searched for: Author/Creator Machimura, Hideo

Search Results

1. Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models. Issue 1 (10th July 2020)

2. Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists. (March 2022)

3. Cross-National Variation in Glycemic Control and Diabetes-Related Distress Among East Asian Patients Using Insulin: Results from the MOSAIc Study. Issue 2 (June 2016)

4. Effects of 1‐year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes. Issue 12 (12th August 2021)

5. Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study. Issue 5 (25th April 2020)

6. Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease. (3rd November 2019)

7. Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring. (3rd October 2019)

8. Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease. (January 2019)